ADS BIOTEC ANNOUNCES IMMEDIATE AVAILABILITY OF ITS
COVID-19 RAPID ANTIGEN TEST THAT WORKS WITH BOTH NASAL SWAB AND
BLOOD SAMPLES

First COVID-19 Antigen Test to work with both nasopharyngeal swab and blood samples, providing qualitative indication for COVID-19 within 15 minutes with demonstrated sensitivity above 97% and specificity of 99% in clinical studies.

January 11, 2021 – Glasgow UK: ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories announces the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company has obtained CE mark for the industry’s first Rapid Antigen Test that works with both nasal swab and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.

YIG-AR-0010-SARS-CoV-2 Antigen Rapid Test Kit

SARS-CoV-2 Antigen Rapid Test Kit

ADS Biotec’s new COVID-19 Rapid Antigen Test works with both nasal swab samples, which are widely used and easy to collect, as well as human blood-derived samples that offer high antigen stability reduces issues from sampling inconsistency. This novel Rapid Antigen Test offers a flexible and affordable solution with excellent performance for detecting active coronavirus infections at large scale. The sensitivity and specificity of the product for both types of samples are above 96% and 99% respectively, with the Limit of Detection (LOD) below 50 TCID50/ml. The test kits come complete with all required reagents and consumables, and are easy to use, and provide qualitative visual interpretation within 15 minutes.

”With a production capacity of over 25 million tests per month and our commitment to quality and reliability, we are able to quickly provide these tests anywhere in Europe and other countries where CE mark is recognized”, said Stavros Papadimitriou, Vice President of Marketing at ADS Biotec. “The results of our COVID-19 Rapid Antigen Test have been validated by European and other clinical laboratories”.

The COVID-19 Rapid Antigen Tests are currently available from stock with production rates of over 1M tests per day. ADS Biotec, with over 20 years of proven experience as a trusted supplier to the clinical community, is proud to offer this cost efficient COVID-19 detection test with assurance of quality and reliability.

About ADS Biotec

ADS Biotec is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology, molecular biology and research laboratories. Our flagship HANABI Metaphase Chromosome Harvesters and Spreaders designed for use by cytogenetic laboratories provide increased productivity and automated throughput with reliable and consistent quality. ADS Biotec has a global presence with development, sales, and support operations on three continents, and supports system users in over 30 Countries. We are recognized by our customers for our advanced instrumentation, superior customer service, scientific application support, and its very knowledgeable sales force.

For More Information:

ADS Biotec Inc.
Stavros Papadimitriou – Vice President of Marketing
info@adsbiotec.com
www.adsbiotec.com